Clinical TrialID 7188

Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis

NCT02029066

Actinic Keratosis

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7188
Evidence Id
7188
Core Evidence Id
7188
Source Clinical Trial Id
7177
Herb2 Clinical Trial Id
HBCT007177
Nct Id
NCT02029066
Title
Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
Status
Completed
Phase
Phase 1
Study Result
No
Study Condition
Actinic Keratosis
Study Type
Interventional
Study Design
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
Intervention
DRUG: SR-T100 gel
Intervention Allocation
Intervention Model
Single_Group
Intervention Mask
Intervention Purpose
Gender
All
Age
Adult, Older_Adult
Enrollment
2
Outcome Measure
To assess the delivery of SR-T100 from the topical gel by determining the plasma solamargine levels in subjects with AK within a 100 cm^2 treatment area., Twelve Subjects will participate in this study. Each patient will be taken blood samples (6 ml for each) before and after applying of SR-T100 at 0, 0.5, 1, 1.5, 2,2.5, 3, 4, 5, 6, 8, 10,12,16, 20, 24, 28, 34, and 36 hour. Plasma solamargine will be analyzed from blood samples using a bioanalytical method. Pharmacokinetic parameters such as AUC0-t, AUC0-infinity, Cmax Tmax, T½, λz, clearance and MRT will be calculated from plasma concentrations of solamargine and presented in the final report., 33 days
Sponsor Collaborator
G&E Herbal Biotechnology Co., LTD
Funded By
INDUSTRY
Location
National Cheng Kung University Hospital, Tainan, 70403, Taiwan
Other Id
GESRTAKC|1025023899
Start Date
2013-11
Primary Completion Date
2014-02
Completion Date
2014-02
First Posted
2014-01-07
Results First Posted
Last Update Posted
2015-08-13
Study Document
Study Url
https://clinicaltrials.gov/study/NCT02029066
Title Cn
Title En
Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
Bilingual Status
semi_complete